XML 20 R10.htm IDEA: XBRL DOCUMENT v3.4.0.3
Revenues
 3 Months Ended
Mar. 31, 2016
Segment Reporting [Abstract]  
REVENUES
REVENUES
Product Revenues
The Company’s net revenues consisted of the following for the three months ended March 31, 2016 and 2015:
 
Three months ended March 31,
 
2016
 
2015
Products:
 
 
 
Acetadote
$
1,837,462

 
$
1,543,009

Omeclamox-Pak
760,319

 
758,191

Kristalose
3,617,806

 
4,098,778

Vaprisol
368,047

 
1,023,990

Caldolor
1,071,968

 
1,194,681

Other
81,930

 
68,125

Total net revenues
$
7,737,532

 
$
8,686,774


Cumberland supplies Perrigo Company ("Perrigo") with an Authorized Generic version of the Company's Acetadote product. The Company's revenue generated by sales of its Authorized Generic distributed by Perrigo is included in the Acetadote product revenue presented above. The Company's share of Authorized Generic revenue was $1.2 million and $0.5 million for the first quarter of 2016 and 2015, respectively.